RCT: Molnupiravir reduced the risk of hospitalization or death in at-risk (i.e., obesity, over 60 years, etc.) unvaccinated adults with Covid-19.
17 Dec, 2021 | 09:52h | UTCRelated: Merck’s COVID pill loses its lustre: what that means for the pandemic – Nature (several articles on the subject)